NASDAQ:AVR Anteris Technologies Global (AVR) Stock Price, News & Analysis $3.07 -0.11 (-3.46%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About Anteris Technologies Global Stock (NASDAQ:AVR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get AVR alerts:Sign Up Key Stats Today's Range$3.01▼$3.3450-Day Range$3.18▼$5.3752-Week Range$2.34▼$8.79Volume183,420 shsAverage Volume221,452 shsMarket Capitalization$110.71 millionP/E RatioN/ADividend YieldN/APrice Target$16.50Consensus RatingBuy Company Overview Anteris Technologies Global Ltd (NASDAQ: AVR) is a commercial-stage life sciences company specializing in advanced biomaterials and protective medical devices. The company’s core mission is to develop and deliver innovative solutions that address musculoskeletal and cardiovascular disorders. By leveraging proprietary biomaterial processing technologies, Anteris aims to improve both the safety profile and long-term performance of implantable devices used in clinical settings around the world. One of Anteris’s flagship products is a noninvasive head-emphasizing device designed to reduce the risk and severity of mild traumatic brain injury in contact sports. In parallel, the company has established a tissue engineering platform for heart valve applications, utilizing a novel pericardial scaffold that seeks to enhance valve durability and biocompatibility. Anteris’s pipeline also includes next-generation soft tissue repair matrices intended for orthopedic and spinal surgery, where improved healing and reduced inflammatory response are key objectives. Founded in 2012, Anteris Technologies Global maintains a dual presence in the United States and Australia, with research laboratories in Brisbane and a commercial office in Minneapolis. The company has navigated a series of regulatory milestones, securing CE mark approval in Europe and pursuing additional clearances in North America and Asia. Its global footprint allows it to collaborate with leading academic institutions and clinical trial sites across multiple continents. Anteris’s leadership team brings together seasoned professionals from the medical device and biotechnology sectors, with expertise spanning biomedical engineering, regulatory affairs, and global commercial operations. The company has established partnerships with contract manufacturers and contract research organizations to support scalable production and streamline clinical development, positioning it for continued growth in the regenerative medicine and protective device markets.AI Generated. May Contain Errors. Read More Receive AVR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Anteris Technologies Global and its competitors with MarketBeat's FREE daily newsletter. Email Address AVR Stock News HeadlinesAnteris Technologies Global (ASX:AVR) Will Have To Spend Its Cash WiselyJuly 9, 2025 | uk.finance.yahoo.comAVR - Anteris Technologies Global Corp Valuation - MorningstarJuly 5, 2025 | morningstar.comM3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. July 14 at 2:00 AM | Timothy Sykes (Ad)Anteris Technologies Global Inc News (AVR) - Investing.comJuly 4, 2025 | investing.comAVR Anteris Technologies Global Corp. - Seeking AlphaJuly 2, 2025 | seekingalpha.comAVR | Anteris Technologies Global Corp. Company Profile & Executives - WSJ - The Wall Street JournalJuly 2, 2025 | wsj.comAVR Anteris Technologies Global Corp.June 14, 2025 | seekingalpha.comAnteris Technologies Global (ASX:AVR) investors are sitting on a loss of 66% if they invested three years agoJune 14, 2025 | uk.finance.yahoo.comSee More Headlines AVR Stock Analysis - Frequently Asked Questions How have AVR shares performed this year? Anteris Technologies Global's stock was trading at $5.58 on January 1st, 2025. Since then, AVR stock has decreased by 45.0% and is now trading at $3.07. How were Anteris Technologies Global's earnings last quarter? Anteris Technologies Global Corp. (NASDAQ:AVR) released its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.61) earnings per share (EPS) for the quarter. When did Anteris Technologies Global IPO? Anteris Technologies Global (AVR) raised $89 million in an initial public offering (IPO) on Friday, December 13th 2024. The company issued 14,800,000 shares at a price of $6.00 per share. When did the company's lock-up period expire? Anteris Technologies Global's lock-up period expired on Wednesday, June 11th. Anteris Technologies Global had issued 14,800,000 shares in its initial public offering on December 13th. The total size of the offering was $88,800,000 based on an initial share price of $6.00. Since the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted. How do I buy shares of Anteris Technologies Global? Shares of AVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/13/2025Today7/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:AVR Previous SymbolNASDAQ:AVR CIK2011514 WebN/A Phone(651) 493-0606FaxN/AEmployees138Year FoundedN/APrice Target and Rating Average Price Target for Anteris Technologies Global$16.50 High Price Target$22.00 Low Price Target$9.00 Potential Upside/Downside+437.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio3.67 Quick Ratio3.65 Sales & Book Value Annual Sales$2.49 million Price / Sales44.41 Cash FlowN/A Price / Cash FlowN/A Book Value$1.74 per share Price / Book1.76Miscellaneous Outstanding Shares36,062,000Free FloatN/AMarket Cap$110.71 million OptionableN/A BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:AVR) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anteris Technologies Global Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anteris Technologies Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.